Here's Why Cara Therapeutics Rose 18.7% in September

0
52

What happened Shares of Cara Therapeutics NASDAQ CARA rose nearly 19 last month according to data provided by S amp P Global Market Intelligence There wasn t any news in September but the small cap pharma company has erupted onto the scene in 2018 thanks to its

Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here